Louapre C, Rosenzwajg M, Golse M, Roux A, et al. A randomized double-blind placebo-controlled trial of low-dose interleukin-2 in relapsing-remitting multiple sclerosis. J Neurol 2023 May 28. doi: 10.1007/s00415-023-11690.
PMID: 37245191